development and validation of spectrophotometric method …€¦ · · 2016-06-02 ic value –...
Post on 17-Apr-2018
243 Views
Preview:
TRANSCRIPT
Vol - 4, Issue - 3, Supl - 1 Apr-Jul 2013 ISSN: 0976-7908 Modi et al
www.pharmasm.com IC Value – 4.01 268
PHARMA SCIENCE MONITOR
AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES
DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC
METHOD FOR SIMULTANEOUS ESTIMATION OF DICLOFENAC
POTASSIUM AND FEBUXOSTAT IN TABLET DOSAGE FORMS.
Modi NR*, Mothalia CP, Prajapati KR, Parmar RR, Shah VN, Shah DA
Department of Quality Assurance, APMC College of Pharmaceutical Education and Research, College campus, Motipura, Himatnagar-383001, Gujarat-INDIA.
ABSTRACT In the present study deals the simultaneous estimation of Diclofenac potassium and Febuxostat in combined tablet dosage form have been developed using 0.1 N NaOH as a solvent. Two method is developed one is simultaneous equation method at 275 nm and 314.5 nm. The second is the Q – analysis (absorption ratio) method, which involves the formation of absorbance equation at 293 nm (isoabsorptive point) and at 314.5 nm the (maximum absorption of Febuxostat). Beer’s law Obeyed in concentration range of 6-30 μg/ mL and 3-15 μg/ mL for Diclofenac potassium and Febuxostat respectively. The accuracy of the methods was assessed by recovery studies was found to be 99.60 ± 0.389 and 99.74 ± 0.213 for simultaneous equation method and 99.74 ± 0.166 and 99.72 ± 0.200 for Q analysis (absorption ratio) method for Diclofenac potassium and Febuxostat respectively. These methods are simple, accurate and rapid; those require no preliminary separation and can therefore be used for routine analysis of both drugs in quality control laboratories. Keywords: Diclofenac potassium , Febuxostat, Simultaneous equation method ,Q–analysis spectrophotometric method. INTRODUCTION
Diclofenac Potassium chemically it is -[(2, 6-dichlorophenyl) amino] benzene acetic acid
monopotassium salt, with a molecular weight of 334.25 g/mol. The empirical formula is
C14H10C12KNO2. It comes under the category of Non-steroidal anti-inflammatory agent
and inhibits prostaglandin synthesis.It is official in British Pharmacopeia, United States
Pharmacopeia and European Pharmacopeia[1-5]. Febuxostat is a xanthine oxidase
inhibitor. The active ingredient in Febuxostat is 2-[3- cyano-4-(2-methylpropoxy)
phenyl]-4-methylthiazole- 5-carboxylic acid, with a molecular weight of 316.38 g/mol.
The empirical formula is C16H16N2O3S. It was recently approved by the European
Medicines Agency on February 21, 2008 and USFDA on Feb 13, 2009[6-9]. Febuxostat is
not official in any pharmacopoeia.The chemical structures of DKP & FEB
shown.Fig.1&2. The combined dosage forms of DKP and FEB are available in the
Vol - 4, Issue - 3, Supl - 1 Apr-Jul 2013 ISSN: 0976-7908 Modi et al
www.pharmasm.com IC Value – 4.01 269
market for the treatment of GOUT. Deep literature survey reveals that, not a single
analytical method is reported for the determination of these drugs in combined
dosage forms. The present manuscript describes simple, accurate, precise, rapid
and economic spectrophotometric methods for simultaneous estimation of DKP and FEB
in tablet dosage form using 0.1 N NaOH as a solvent.
FIG.1 Chemical structure of Diclofenac Potassium(DKP).
Fig.2 Chemical structure of Febuxostat(FEB).
MATERIALS AND METHODS
Chemicals and Reagents
DKP and FEB bulk powder was kindly gifted by A.P.M.C. Pharmacy College,
Himatnagar, Gujarat, India and Intas Pharmaceuticals, Ahmedabad, Gujarat, India.
Respectively the commercial fixed dose combination XANFEB DSR was procured from
the local market. All other chemicals used were analytical grade. 0.1 N NaOH and
caliberated glass wares were employed throughout the work.
Apparatus
A shimadzu model 1700 (Japan) double beam UV/Visible spectrophotometer with
spectral width of 2 nm, wavelength accuracy of 0.5 nm and a pair of 10 mm matched
quartz cell was used to measure absorbance of all the solutions. A Reptech
electronic weighing analytical balance based on EMFC technology and a Toshcon
Vol - 4, Issue - 3, Supl - 1 Apr-Jul 2013 ISSN: 0976-7908 Modi et al
www.pharmasm.com IC Value – 4.01 270
ultrasonic bath (Toshniwal process instrument pvt ltd.) was used in the study.
Preparation of standard stock solutions
An accurately weighed quantity of DKP (10 mg) and FEB (10 mg) were transferred to a
separate 100 ml volumetric flask and dissolved in 10 ml methanol and diluted to the
mark with 0.1 N NaOH to obtain standard solution having concentration of DKP (100
μg/ml) and FEB (100 μg/ml).
Method 1 :
The standard solutions of DKP (10 μg/ml) and FEB (10 μg/ml) were scanned separately
in the UV range of 200-400 nm to determine λmax of both the drugs. The λmax of DKP
and FEB were found to be 275 nm and 314.5 nm respectively (Fig.3). Five standard
solutions having concentration 6, 12, 18, 24 and 30 μg/ml for DKP and 3, 6, 9, 12 and 15
μg/ml for FEB were prepared in 0.1 N NaOH using the solutions having concentration
100 μg/ml. The absorbance of resulting solutions was measured at 275 nm
and 314.5 nm and calibration curves were plotted at these wavelengths. The
absorptivity coefficients of these two drugs were determined using calibration curve
equations. The concentration of DKP and FEB in sample solution was determined by
solving the respective simultaneous equations generated by using absorptivity
coefficients and absorbance values of DKP and FEB at these wavelengths. The
absorbance and absorptivities values at the particular wavelength were substituted in
the following equations to obtain the concentration[25].
. . . (1)
. . .(
Where,
A1, A2 –– absorbance of the mixture,
ax1 , ax2 – denotes absorptivities of the x at 275 nm and 314.5nm respectively,
ay1 , ay2 –– denotes absorptivities of Y at 275nm and 314.5 nm respectively,
CX = concentration of DKP.
CY = concentration of FEB.
Vol - 4, Issue - 3, Supl - 1 Apr-Jul 2013 ISSN: 0976-7908 Modi et al
www.pharmasm.com IC Value – 4.01 271
Fig.3 : Overlain Spectra of Diclofenac potassium(DKP) and Febuxostat(FEB).
Method 2:
The standard solutions of DKP (10 μg/ml) and FEB (10 μg/ml) were scanned in the UV
range of 200-400 nm to determine isoabsorptive point. The isoabsorptive point was
found to be 293nm (Figure.3).Five standard solutions having concentration 6, 12, 18, 24
and 30 μg/ml for DKP and 3, 6, 9, 12 and 15 μg/ml for FEB were prepared in 0.1 N
NaOH using the solutions having concentration 100 μg/ml. The absorbance of resulting
solutions was measured at 293 nm (isoabsorptive point) and 314.5 nm (λmax of FEB) and
calibration curves were plotted at these wavelengths. The absorptivity coefficients of
these two drugs were determined using calibration curve equations. The concentration of
DKP and FEB in sample solution was determined by solving the respective Q-analysis
equations generated by using absorptivity coefficients and absorbance values of DKP and
FEB at these wavelengths. The absorbance and absorptivities values at the particular
wavelength were substituted in the following equations to obtain the concentration[25].
For DKP
. . . (3)
For FEB
. . . (4)
Vol - 4, Issue - 3, Supl - 1 Apr-Jul 2013 ISSN: 0976-7908 Modi et al
www.pharmasm.com IC Value – 4.01 272
Where,
A1 = Absorbance of sample at isoabsorptive point,
ax1 = Absorptivities of DKP at isoabsorptive point.
Validation of the proposed method:
The proposed methods were validated according to the International Conference on
Harmonization (ICH) guidelines[26].
Linearity (Calibration curve)
The calibration curves were plotted over a concentration range of 6-30 μg/ml and 3-
15 μg/ml for DKP and FEB respectively for Simultaneous equation and Q-analysis.
Accurately measured standard solutions of DKP ( 6, 12, 18, 24 & 30 ml) and FEB (3, 6,
9, 12 and 15 ml) were transferred to a series of 100 ml of volumetric flasks and diluted
to the mark with 0.1 N NaOH for simultaneous equation Method. Accurately measured
standard solutions of DKP ( 4, 6, 8, 10 & 12 ml) and FEB (3, 6, 9, 12 and 15 ml) were
transferred to a series of 100 ml of volumetric flasks and diluted to the mark with 0.1 N
NaOH for Q-analysis Method. The absorbances of the solutions were measured at 275
and 314.5 nm against 0.1 N NaOH as blank for simultaneous equation Method. The
absorbances of the solutions were measured at 293 and 314.5 nm against 0.1 N NaOH as
blank for Q-analysis Method. The calibration curves were constructed by plotting
absorbances versus concentrations and the regression equations were calculated.
Precision
The intraday and interday precision of the proposed methods was determined by
analyzing the corresponding responses 3 times on the same day and on 3 different days 3
Vol - 4, Issue - 3, Supl - 1 Apr-Jul 2013 ISSN: 0976-7908 Modi et al
www.pharmasm.com IC Value – 4.01 273
different concentrations of standard solutions of DKP and FEB for both methods.
Accuracy (recovery study)
The accuracy of the method was determined by calculating recovery of DKP and FEB by
the standard addition method. Known amounts of standard solutions of DKP and FEB
were added at 80, 100 and 120 % level to prequantified sample solutions of DKP and
FEB. (100 μg/ml for DKP and 40 μg/ml for FEB) The amounts of DKP and FEB
were estimated by applying obtained values to the respective regression line equations.
The experiment was repeated for five times for both methods.
Limit of detection and Limit of quantification
The limit of detection (LOD) and the limit of quantification (LOQ) of the drug were
derived by calculating the signal-to- noise ratio (S/N) using the following equations
designated by International Conference on Harmonization (ICH) guidelines.
LOD = 3.3 × σ/S
LOQ = 10 × σ/S
Where, σ = the standard deviation of the Intercept of Caliberation curve and S = slope of
the calibration curve.
Analysis of DKP and FEB in combined Dosage Form (Tablet)
Twenty tablets were accurately weighed and average weight was calculated. The tablets
were triturated to a fine powder. An accurately weighed quantity of powder equivalent
to 100 mg DKP & 40mg FEB was dissolved in 10 ml methanol and sonicated for 20
min and volume was made up to 100ml. The solution was filtered through Whatman
filter paper No 41 and aliquot portion of filtrate was diluted to produce solution having
concentration of 10 μg/ml of DKP and 4 μg/ml of FEB. The absorbance of sample
solution was measured at selected wavelengths and the concentrations of the two drugs
were estimated using equations (1) and (2) for simultaneous equation method
and equations (3) and (4) for absorbance ratio method. The analysis procedure was
repeated six times and the results are depicted in Table 2.
RESULTS AND DISCUSSION
Vol - 4, Issue - 3, Supl - 1 Apr-Jul 2013 ISSN: 0976-7908 Modi et al
www.pharmasm.com IC Value – 4.01 274
TABLE 1: REGRESSION ANALYSIS DATA AND SUMMARY OF VALIDATION
PARAMETER OF THE CALIBERATION CURVES
Sr No
Parameters Method 1 Method 2
DKP FEB DKP FEB 1 Wavelength(nm) 275 314.5 275 314.5 293 314.5 293 314.5 2 Beer’s law limit
(μg /ml) 6-30 6-30 3-15 3-15 6-30 6-30 3-15 3-15
3 Regression equation (y = mx + c)
y = 0.031x - 0.011
y = 0.003x- 0.004
y = 0.016x- 0.014
y = 0.063x - 0.031
y = 0.020x - 0.001
y = 0.003x- 0.004
y = 0.040x - 0.020
y = 0.063x - 0.031
4 Slope (m) 0.031 0.003 0.016 0.063 0.020 0.003 0.040 0.063 5 Intercept (c) 0.011 0.004 0.014 0.031 0.001 0.004 0.020 0.031 6 Correlation
coefficient(r2) 0.9997 0.9985 0.9984 0.9991 0.9997 0.9985 0.9985 0.9991
7 LOD (μg/ml) 0.25 0.80 0.02 0.16 0.23 0.80 0.12 0.16 8 LOQ (μg/ml) 0.77 2.43 0.07 0.49 0.70 2.43 0.38 0.49 Precision(% RSD) 9 Interday(n=3) 0.77 1.38 0.95 0.55 0.71 1.38 0.61 0.55 10 Intrady(n=9) 0.88 1.69 1.42 1.04 1.23 1.69 1.10 1.04
TABLE 2: RESULTS OF RECOVERY STUDIES
Level of recovery
Amount of pure drug added (ml)
Simultaneous equation Method
% recovery
Q-Absorbance
method %Recover
DKP (100ug/ml)
FEB (100ug/ml)
DKP FEB DKP FEB
80 % 18 7.2 99.915 99.803 99.551 99.848
100 % 20 8.0 99.169 99.917 99.850 99.833
120 % 22 8.8 99.739 99.504 99.827 99.493
Mean % recovery 99.60767 99.74133 99.74267 99.72467
SD 0.389956 0.213294 0.166386 0.200769
RSD 0.391492 0.213847 0.166815 0.201324
Vol - 4, Issue - 3, Supl - 1 Apr-Jul 2013 ISSN: 0976-7908 Modi et al
www.pharmasm.com IC Value – 4.01 275
The overlain spectra of DKP and FEB exhibit λ max of 275 nm and 314.5 nm for DKP
and FEB respectively which are quite separated from each other. Additionally one
isoabsorptive point was observed at 293nm. This wavelength was selected for
simultaneous estimation of DKP and FEB for Q value analysis and it is assumed to be
sensitive wavelength. The criteria for obtaining maximum precision by Simultaneous
equation method were calculated and found to be out side the range 0.1-2 and for Q-
analysis ratios of absorbances at 2 different Wavelengths were found to be constant.
Standard calibration curves for DKP and FEB were linear with correlation coefficients (r)
values in the range of 0.9984 – 0.9997 at all the selected wavelengths and the values were
average of three readings with standard deviation in the range of 0.0015 – 0.0045. The
calibration curves were repeated three times in a day and the average % RSD was found
to be 0.86 for DKP and 0.70 for FEB; similarly the method was repeated for three
different days and average % RSD was found to be for 1.26 DKP and 1.18. for FEB . The
accuracy of the methods was confirmed by recovery studies.
CONCLUSION
The proposed methods for simultaneous estimation of DKP and FEB were found to be
simple, accurate, economical and rapid. Due to accuracy, precision and sensitivity, the
developed simultaneous equation method and Q-ratio method could be used for routine
analysis of DKP and FBE in tablet dosage forms.
ACKNOWLEDGEMENT
The authors are thankful to Intas Pharmaceutical, Ahmedabad, Gujarat, India for providing
DKP and FEB for research.
REFERENCES:
1. British pharmacopoeia 2009, volume I & II, III, British Pharmacopoeial
commission, London SW85NQ,1889-1892.
2. European pharmacopoeia 2005, volume II, 5th edition, European pharmacopoeia
commission,1419-1420.
3. United state pharmacopoeia 30- National formulary 25, United state
pharmacopoeial convention,1971.
Vol - 4, Issue - 3, Supl - 1 Apr-Jul 2013 ISSN: 0976-7908 Modi et al
www.pharmasm.com IC Value – 4.01 276
4. Drug Information Online Diclofenac potassium [Online]. 2013 Feb 17 [Cited
2013 Feb 19]; Available from: URL:http://www.drugs.com/pro/diclofenac-
potassium.html
5. Drug Bank Diclofenac [Online]. 2013 Feb 08 [Cited 2013 Feb 15]; Available
from: URL:http://www.drugbank.ca/drugs/DB00586
6. Rxlist Febuxostat [Online]. 2012 Nov 16 [Cited 2012 Dec 15]; Available from:
URL: http://www.rxlist.com/uloric-drug.htm
7. Medlineplus Febuxostat [Online]. 2009 Jan 06 [Cited 2012 Dec 15]; Available
from: URL: http://www.nlm.nih.gov/medlineplus/druginfo/meds/a609020.html
8. European Medicines Agency Evaluation of Medicines for Human Use, Chmp
Assessment Report, 2008, 258531
9. Approved Drug Products With Therapeutic Equivalence Evaluations, 32nd
edition
,Cumulative Supplement 9 ,September 2012.
10. Bagga. P, Mohd. S, Siddiqui. H, Ansari. A, Mehmood. T And Singh. K. Simple
Uv Spectrophotometric Method For The Determination Of Febuxostat In Bulk
And Pharmaceutical Formulations. IJPSR. 2: 2655-2659, 2011.
11. Lakade. S, Bhalekar.M. Development And Validation Of New
Spectrophotometric Method For Determination Of Febuxostat In Tablet Dosage
Forms. Journal of Pharmacy Research 4(9): 3122-3123, 2011.
12. Sheth M, Joshi. S And Patel. M .Development And Application Of Difference
Spectrophotometric Method For The Determination Of Febuxostat In Tablets.
IJPSR 3(6): 1621-1624, 2012.
13. Kumaraswamy G, Kumar J, Sheshagirirao J. Simultaneous Estimation Of
Febuxostat And Ketorolac In Pharmaceutical Formulations By Spectroscopic
Method. Int.J. ChemTech Res 4(2):847-850, 2012.
14. Gandla K, Kumar J, Bhikshapathi D, Gajjela V, Spandana R .A Validated RP-
HPLC Method For Simultaneous Estimation Of Febuxostat And Ketorolac
Tromethamine In Pharmaceutical Formulations. Journal of Drug Delivery &
Therapeutics 2(3):173-176, 2012.
Vol - 4, Issue - 3, Supl - 1 Apr-Jul 2013 ISSN: 0976-7908 Modi et al
www.pharmasm.com IC Value – 4.01 277
15. Kumar A , UmaShankar M , Singh P, and Shah G. Simultaneous
Spectrophotometric Estimation of Diclofenac Potassium and Tizanidine
Hydrochloride in Bulk and Solid Dosage Forms. International Journal of
Institutional Pharmacy and Life Sciences, 1(1):316-327, 2011.
16. Mehta S, Umarkar A, Chaple D and Thote L .Development of UV
Spectrophotometric Methods for Simultaneous Estimation of Famotidine and
Diclofenac Potassium in Combined Dosage Form Using Simultaneous Equation
Method. Journal of Pharmacy Research, 4(7): 2045-2046, 2011.
17. Patil V and Chaudhari R . Spectrophotometric method for estimation of
thiocolchicoside and diclofenac potassium in capsule dosage form by
simultaneous equation method. Int. J. of Drug Discovery & Herbal Research 2(2):
410-412,2012.
18. Gabhane K, Kasture A, Shrikhande V, Barde L and Wankhade V . Simultaneous
Spectrophotometri Determination Of Metaxalone And Diclofenac Potassium In
Combined Tablet Dosage Form. Int. J. Chem. Sci. 7(1): 539-545,2009.
19. Kumar R, Karthikeyan C, Moorthy N, Trivedi P .New spectrophotometric
methods applied to the simultaneous determination of diclofenac potassium and
tizanidine. Indian Jou Ph Sci 68(3):317-322,2006.
20. Umarkar A, Bagad Y, Bhurat M, Kawatikwar P . Absorption Correction Method
for Estimation of Thiocolchicoside and Diclofenac Potassium in Combined
Capsule Dosage Form. INT.J.PH.SCI. 3(1):1046-1049,2011.
21. Ingale S, Abnawe S, Shinde S, More A, Choudhari V and Kuchekar B.
Simultaneous Spectrophotometric Estimation of Drotaverine Hydrochloride and
Diclofenac Potassium in Combined Dosage Form. RJPT 3(4): 1118-1122, 2010.
22. Mehta K, Shyam B and Dubeyakhilesh .Development And Validation For
Simultaneous Estimation Of Famotidine And Diclofenac Poatassium In
Combined Tablet Dosage Form By First Order Derivative Method. Int J Of
Research In Pharmacy And Chemistry 2(4):1023-1028, 2012.
23. Patel C, Kimbahune R, Kabra P, Harish A and Nargund L. Spectrophotometric
Estimation of Metaxalone and Diclofenac Potassium by Multicomponent
Vol - 4, Issue - 3, Supl - 1 Apr-Jul 2013 ISSN: 0976-7908 Modi et al
www.pharmasm.com IC Value – 4.01 278
Analytical Method from Tablet Dosage Form. J Anal Bioanal Techniques, 3(3):
137-139, 2012.
24. Umarkar A, Rewatkar N, Charde M, ChardeR. Simultaneous Estimation of
Thiocolchicoside and Diclofenac Potassium by UV Spectrophotometer Using
Multicomponent Method. Int J Of Research In Pharmacy And Chemistry 3(2):
944-947, 2011.
25. Beckett AH, Stenlake JB. Practice Pharmaceutical Chemistry. 4th Edition, Part II.
New Delhi: CBS Publisher;(1997): 285-288.
26. ICH, Q2 (R1) Validation of Analytical Procedure: Text and Methodology,
International Conference on Harmonization, Geneva, Switzerland; 2005.
For Correspondence: Modi NR Email: modinirav2@yahoo.com
top related